Skip to content

QuickVue 20183

by Quidel Corp.

Ref 20183Model QuickVue Influenza A+B Test

QuickVue 20183 is an influenza A/B virus antigen IVD (EU IVDD general IVD; FDA Class I; FDA product code GNX, Antigens, Cf (Including Cf Control), Influenza Virus A, B, C) made by Quidel Corp., registered in EUDAMED on 4 Nov 2026 (Basic UDI-DI B-30014613201830) and listed in FDA GUDID since 10 Nov 2018 (UDI-DI 30014613201830), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-30014613201830 Basic UDI-DI 30014613201830UDI-DIDate4 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number30014613201830 UDI-DI Date10 Nov 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
QkVue Flu A+B 25T, CE
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-30014613201830 registered 4 Nov 2026 Active
  • FDA GUDID UDI-DI 30014613201830 listed 10 Nov 2018 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Listed FDA GUDID 30014613201830
  2. Registered EUDAMED B-30014613201830

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
QuickVue Influenza A+B Test EUDAMED
QuickVue GUDID
Generic name
Influenza A/B virus antigen IVD, kit, rapid ICT, clinical
Model / Ref / Catalog
20183, QuickVue Influenza A+B Test
Primary DI / UDI-DI
30014613201830
Basic UDI-DI
B-30014613201830
FDA product code
GNX
EMDN code
W0105099004 Influenza a and /or b - rt & poc
GMDN term
Influenza A/B virus antigen IVD, kit, rapid ICT, clinical
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
866.3330
EU registration type
Legacy device (under a directive)
EU market of registration
Austria
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under INFLUENZA A AND /OR B - RT & POC.

Other devices from Quidel Corp.

See all devices from Quidel Corp. →

Properties

  • Single use
  • Contains animal tissues or cells
  • IVD kit
  • Near-patient testing
  • Professional testing
  • Prescription use
  • Convenience kit
  • Expiration date
Other properties (18, all answered No)